Ming-rui Huo
Beijing Key Laboratory Of Hematopoietic Stem Cell Transplantation
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse.
Journal: Bone marrow transplantation
Published: June 18, 2025
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: July 26, 2021
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation.
Journal: JCI insight
Published: February 26, 2021
Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
Journal: Bone marrow transplantation
Published: November 15, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody.
Journal: Bone marrow transplantation
Published: October 27, 2019
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.
Journal: Human immunology
Published: April 01, 2018
Evaluation of HistoCheck as a Predictor of Clinical Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: January 25, 2018
Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
Journal: Bone marrow transplantation
Published: July 19, 2017
Predicted indirectly recognizable HLA epitopes are not associated with clinical outcomes after haploidentical hematopoietic stem cell transplantation.
Journal: Human immunology
Published: June 22, 2017
Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.
Journal: British journal of haematology
Published: August 15, 2016
Last Updated: 09/26/2026